...
首页> 外文期刊>Hematology >Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings
【24h】

Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings

机译:先天性贫血性贫血,具有SEC23B外显子​​12 c.1385 A→G突变的II型和两个兄弟姐妹中的伪高雪氏细胞

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective and importance Congenital dyserythropoietic anemia (CDA) represents a genotypically and phenotypically heterogeneous group of disorders. CDA type II, the most frequent variant, was recently shown to be caused by mutations in the gene encoding the secretory COPII component SEC23B. We report two siblings hailing from Punjab in northern India with classical CDA type II where this mutation was demonstrated. Clinical presentation A 7-year-old girl presented with transfusion-dependent anemia, splenomegaly, and progressive growth failure since 1 year of age. Her 5-year-old brother was similarly afflicted, but there was no other family history. Extensive prior work-up for hemolytic anemia, storage and metabolic disorders, and infectious diseases was negative. Hemoglobin was 71 g/l with normal leukocyte, platelet, and corrected reticulocyte counts. Bone marrow examination revealed marked normoblastic erythroid hyperplasia with dyserythropoiesis (36%) and the presence of bi- and multinucleated erythroblasts with equal-sized nuclei. Many pseudo-Gaucher cells were also seen. Iron stores were increased although ring sideroblasts were absent. Hereditary erythrocyte multinuclearity with positive acidified serum (HEMPAS) test revealed lysis of the red cells in four out of five control sera. Technique Genomic DNA sequencing of the SEC23B exon 12 revealed homozygosity for c.1385 A → G; Y462C mutations in both siblings. Conclusion CDA has traditionally been a difficult diagnosis to establish, since it requires exclusion of other causes of dyserythropoiesis and the performance of complex tests including HEMPAS and electron microscopy for confirmation. The availability of molecular genetic testing for SEC23B promises to streamline and hasten the diagnostic process for this rare and intriguing disease.
机译:目的和重要性先天性贫血性贫血(CDA)代表了基因型和表型异质性疾病。最近显示,CDA II型是最常见的变体,是由编码分泌型COPII成分SEC23B的基因突变引起的。我们报告了两个印度兄弟姐妹从印度北部的旁遮普邦招呼的经典CDA类型II,证实了这种突变。临床表现一名7岁女孩自1岁起表现为输血依赖性贫血,脾肿大和进行性生长衰竭。她的5岁弟弟也遭受了类似的折磨,但没有其他家族史。先前对溶血性贫血,贮藏和代谢紊乱以及传染病进行的广泛检查为阴性。血红蛋白为71 g / l,白细胞,血小板正常,网织红细胞计数正确。骨髓检查发现正常的成红细胞增生伴有促红细胞生成障碍(36%),以及双核和多核成核细胞的大小均等。还看到了许多伪高雪氏细胞。尽管不存在环形铁粒母细胞,但铁存储增加。遗传性红细胞多核与阳性酸化血清(HEMPAS)测试显示,五分之四的对照血清中的红细胞溶解。技术SEC23B外显子​​12的基因组DNA测序显示c.1385 A→G是纯合的。两个兄弟姐妹中的Y462C突变。结论CDA传统上难以诊断,因为它需要排除其他原因引起的异常性红细胞增多症,并且需要进行包括HEMPAS和电子显微镜在内的复杂检查以进行确认。 SEC23B的分子遗传学测试有望简化和加快这种罕见而有趣的疾病的诊断过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号